It has been reported that AGRN is important for maintaining the composition of the blood–brain barrier (BBB) in mouse models of AD and that changes in AGRN expression (especially vascular-associated AGRIN) affect a-amyloid (AA) homeostasis (Barber and Lieth, 1997; Berzin et al., 2000). Here, AGRN is linked to Alzheimer disease.